Virtu Financial LLC Buys Shares of 10,786 NEXGEL, Inc. (NASDAQ:NXGL)

Virtu Financial LLC purchased a new stake in shares of NEXGEL, Inc. (NASDAQ:NXGLFree Report) during the 4th quarter, HoldingsChannel reports. The institutional investor purchased 10,786 shares of the company’s stock, valued at approximately $48,000.

Separately, IFP Advisors Inc acquired a new stake in shares of NEXGEL during the fourth quarter worth about $49,000. Institutional investors own 2.21% of the company’s stock.

NEXGEL Trading Up 1.0 %

Shares of NXGL stock opened at $3.01 on Wednesday. NEXGEL, Inc. has a fifty-two week low of $1.84 and a fifty-two week high of $5.10. The company has a 50 day moving average price of $3.17 and a 200 day moving average price of $3.28. The stock has a market capitalization of $20.44 million, a P/E ratio of -5.19 and a beta of 0.62. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.93 and a current ratio of 1.51.

NEXGEL (NASDAQ:NXGLGet Free Report) last posted its quarterly earnings results on Monday, March 24th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.02. NEXGEL had a negative return on equity of 71.19% and a negative net margin of 52.60%. The company had revenue of $3.04 million for the quarter, compared to analyst estimates of $2.99 million.

NEXGEL Company Profile

(Free Report)

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.

Featured Articles

Want to see what other hedge funds are holding NXGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NEXGEL, Inc. (NASDAQ:NXGLFree Report).

Receive News & Ratings for NEXGEL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NEXGEL and related companies with MarketBeat.com's FREE daily email newsletter.